RGNX US Equity
REGENXBIO Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1590877 · FY ends Dec 31$12.02
+0.95 (+8.58%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 7.2M |
| % of shares out | 10.9% |
| Days to cover | 3.8 |
| Δ vs 2026-07-15 | -16.6% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 7,194,939 | -16.6% | 1,897,130 | 3.8 |
| 2026-07-15 | 8,626,772 | -17.5% | 2,618,877 | 3.3 |
| 2026-06-30 | 10,459,575 | +12.9% | 3,279,369 | 3.2 |
| 2026-06-15 | 9,263,377 | +11.8% | 1,331,564 | 7.0 |
| 2026-05-29 | 8,281,637 | +16.1% | 1,838,381 | 4.5 |
| 2026-05-15 | 7,135,749 | +6.6% | 2,233,461 | 3.2 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
